← back to search

Shufeng Ji

Southern Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Oxidative phosphorylation, Osteosarcoma, Apoptosis, Cancer research, Nuclear receptor, and Reprogramming.
h-index
citations
17
works
2
NIH funding
primary concept
email

Recent publications

Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma
Cell Reports Medicine 2024cited by 17position: middledoi
Rorγ Targeting Promotes Apoptosis and Ferroptosis in Osteosarcoma by Reprogramming Mitochondrial Oxidative Phosphorylation
SSRN Electronic Journal 2022cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qianqian Wang · Xuzhou Medical College2 papers (2022–2024)Junjian Wang · Sun Yat-sen University2 papers (2022–2024)Linlin Lu · Sun Yat-sen University2 papers (2022–2024)Hong-Wu Chen · University of Science and Technology of China2 papers (2022–2024)Guodi Cai · Sun Yat-sen University2 papers (2022–2024)Peiqing Liu · General Administration of Quality Supervision, Inspection and Quarantine2 papers (2022–2024)Yanqiu Yuan · Sun Yat-sen University2 papers (2022–2024)Hongye Zou · University of California, Davis2 papers (2022–2024) · 1 papers (2022–2022)Peng Chen · University of California, Davis1 papers (2022–2022)Hong Li · Third People's Hospital of Chengdu1 papers (2024–2024)Sheng Li · Queen's University1 papers (2024–2024)Qianqian Liu · Anhui University of Science and Technology1 papers (2024–2024)Zhenhua Zhang · Nanjing Normal University1 papers (2022–2022)Zhenhua Zhang · Harbin Engineering University1 papers (2024–2024)Jianwei Zheng · Medical College of Wisconsin1 papers (2024–2024)Haibin Wang · Guangzhou University of Chinese Medicine1 papers (2022–2022)Jianwei Zheng · Wenzhou Medical University1 papers (2022–2022)June X. Zou · University of California, Davis1 papers (2024–2024)Jianghe Chen · Sun Yat-sen University1 papers (2024–2024)